Funda Tasli Alkan
Overview
Explore the profile of Funda Tasli Alkan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karatas M, Tatar E, Okut G, Yildirim A, Kocabas E, Tasli Alkan F, et al.
Exp Clin Transplant
. 2024 Feb;
22(Suppl 1):118-127.
PMID: 38385385
Objectives: We investigated the efficacy of a predetermined protocol that consisted of immunosuppressive drug reduction/withdrawal and intravenous immunoglobulin administration for the treatment of polyoma BK virus nephropathy. Materials And Methods:...
2.
Karatas M, Okut G, Simsek C, Dogan S, Zengel B, Tasli Alkan F, et al.
Exp Clin Transplant
. 2022 Apr;
20(Suppl 1):145-148.
PMID: 35384826
Objectives: We investigated patients with genitourinary cancer after kidney transplant and the effects of immunosuppression reduction and switching to mechanistic target of rapamycin inhibitors. Materials And Methods: We retrospectively evaluated...
3.
Simsek C, Karatas M, Tatar E, Tercan I, Tasli Alkan F, Uslu A
Exp Clin Transplant
. 2022 Apr;
20(Suppl 1):117-124.
PMID: 35384820
Objectives: In this study, we examined the clinical and biochemical features of biopsy-proven acute pyelonephritis among 769 kidney transplant recipients. Materials And Methods: This cohort study was performed between January...
4.
Simsek C, Karatas M, Tatar E, Yildirim A, Tasli Alkan F, Uslu A
Exp Clin Transplant
. 2022 Apr;
20(Suppl 1):61-68.
PMID: 35384809
Objectives: Prevention of sepsis-related organ dysfunction in septic donors is crucial. In this study, septic donors were followed-up based on donor Sequential Organ Failure Assessment criteria. Materials And Methods: Between...
5.
Simsek C, Karatas M, Tatar E, Yildirim A, Tasli Alkan F, Uslu A
Clin Transplant
. 2021 Apr;
35(6):e14309.
PMID: 33813772
Background: The efficacy of anti-interleukin-1 (IL-1) drugs in kidney transplant patients with FMF-AA who developed colchicine resistance has not been clearly demonstrated. Method: Thirty nine kidney transplant recipients with FMF-AA...
6.
Tasli Alkan F, Tatar E, Karatas M, Simsek C, Tercan I, Aykas A, et al.
Clin Nephrol
. 2019 Nov;
93(2):85-90.
PMID: 31670649
Background: The aim of this study is to evaluate the efficacy of a treatment protocol for the management of acute antibody-mediated rejection (AAMR) and mixed-type rejection (MTR), both histopathologically and...